Long noncoding RNA LINC00314 facilitates osteogenic differentiation of adipose-derived stem cells through the hsa-miR-129-5p/GRM5 axis via the Wnt signaling pathway

Zhengliang Shi, Hua Zhang, Zhiyong Fan, Wei Ma, Yongzhou Song, Ming Li, Tong-qiu Li, Shuxing Cao, Guo-jun FengStem 2020 · DOI

TL;DR

This study uncovers a novel molecular pathway involving the long noncoding RNA LINC00314, microRNA miR-129-5p, and the gene GRM5 that promotes the differentiation of adipose-derived stem cells (ADSCs) into bone-forming cells (osteoblasts). This axis appears to be a key regulator of osteogenesis and could offer new therapeutic targets for bone diseases like osteoporosis.

What Problem Does This Paper Address?

Osteoporosis, a condition characterized by reduced bone mass and increased fracture risk, poses a significant public health challenge. While bone marrow mesenchymal stem cells (BMSCs) have been explored for bone regeneration, their limited proliferation capacity, especially in older individuals, necessitates alternative cell sources. Adipose-derived stem cells (ADSCs) offer a promising alternative due to their abundance and ease of isolation. However, understanding the intricate molecular mechanisms that drive ADSC differentiation into osteoblasts is crucial for developing effective regenerative therapies. Previous research has implicated long noncoding RNAs (lncRNAs) in bone health, but the specific role of LINC00314 in ADSC osteogenesis and its underlying molecular mechanisms remained largely unexplored.

Methods

The researchers employed a multi-pronged approach to investigate the role of LINC00314 in ADSC osteogenic differentiation:

  • RNA Sequencing: Microarray analysis was used to identify differentially expressed lncRNAs and microRNAs in ADSCs undergoing osteogenic induction compared to normal conditions.
  • Quantitative Real-Time PCR (qRT-PCR): This technique was used to validate the expression levels of LINC00314, miR-129-5p, and GRM5 identified by the microarray.
  • Cell Culture and Transfection: ADSCs were cultured and then transfected with plasmids to overexpress or silence LINC00314, and with mimics or inhibitors for miR-129-5p. This allowed for the manipulation of specific molecular players.
  • Alizarin Red S (ARS) and Alkaline Phosphatase (ALP) Staining: These assays are standard methods to assess the degree of osteogenic differentiation by detecting calcium deposition and ALP activity, respectively.
  • Luciferase Reporter Assay: This assay was used to confirm direct binding interactions between LINC00314 and miR-129-5p, and between miR-129-5p and GRM5.
  • Western Blotting: This technique was used to measure the protein expression levels of key osteogenic markers (RUNX2, Osterix, Osteocalcin) and components of the Wnt/β-catenin signaling pathway (Wnt5a, β-catenin, p-β-catenin).
  • Bioinformatic Analysis: Databases like DAVID and STRING were used to analyze gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and to construct interaction networks.

Datasets

The study utilized human adipose tissue samples for ADSC isolation. The primary datasets generated and analyzed were:

  • Microarray data for lncRNA and microRNA expression profiles from normal and osteogenically induced ADSCs.
  • qRT-PCR data quantifying the expression of specific genes and miRNAs.
  • Western blot data for protein expression levels.
  • Alizarin Red S and Alkaline Phosphatase staining results.

No new public benchmarks were introduced.

Key Insights and Ideas

  • LINC00314 as a Pro-Osteogenic Factor: The study clearly demonstrates that LINC00314 is upregulated during ADSC osteogenic differentiation and that its overexpression promotes this process, while its silencing inhibits it. This positions LINC00314 as a key facilitator of bone formation.
  • The lncRNA-miRNA-mRNA Axis: The research unravels a sophisticated regulatory network where LINC00314 acts as a "sponge" for miR-129-5p, preventing it from inhibiting its target, GRM5. This intricate interplay highlights the complex regulatory mechanisms at play.
  • miR-129-5p as an Osteogenic Inhibitor: Conversely, miR-129-5p was found to be downregulated during osteogenesis and its overexpression suppressed osteogenic differentiation, suggesting it acts as a negative regulator.
  • GRM5 as a Downstream Target: GRM5 was identified as a direct target of miR-129-5p, and its expression was found to be crucial for promoting osteogenesis.
  • Wnt/β-catenin Pathway Activation: The entire LINC00314/miR-129-5p/GRM5 axis ultimately converges on activating the Wnt/β-catenin signaling pathway, a well-established pathway critical for osteoblast differentiation. This provides a mechanistic link between the identified molecules and the osteogenic process.

Key Results

  • LINC00314 expression was significantly upregulated in osteogenically induced ADSCs.
  • Overexpression of LINC00314 increased ALP activity and calcium deposition, while miR-129-5p mimic had the opposite effect.
  • Luciferase reporter assays confirmed that LINC00314 directly targets miR-129-5p, and miR-129-5p suppresses GRM5 expression.
  • The LINC00314/miR-129-5p/GRM5 regulatory axis was shown to activate the Wnt/β-catenin signaling pathway.
  • Experiments with GRM5 inhibitors and mimics, along with Wnt pathway inhibitor XAV939, confirmed GRM5's role in regulating Wnt/β-catenin signaling and promoting osteogenesis.

Limitations and Future Work

  • Limited Clinical Translation: While the study identifies a promising molecular axis, it is currently based on in vitro experiments with ADSCs. Further research is needed to validate these findings in animal models and ultimately in clinical settings for bone regeneration therapies.
  • Specificity of miR-129-5p: The paper notes that miR-129-5p has been implicated in various cancers. Further investigation into its specific roles and potential off-target effects in different cellular contexts would be beneficial.
  • Broader Osteogenic Factors: While the Wnt/β-catenin pathway is central, other signaling pathways and factors involved in osteogenesis might also be influenced by this axis, warranting further exploration.
  • Therapeutic Strategies: The authors suggest that this axis could be a novel target for osteogenic-related diseases. Future work could focus on developing therapeutic strategies that modulate LINC00314, miR-129-5p, or GRM5 to enhance bone formation.

Summary updated

Abstract

LINC00314 confers contributory function in the osteogenic differentiation of ADSCs and thus the LINC00314/miR-129-5p/GRM5 axis may be a novel mechanism for osteogenic-related disease.
BibTeX
@inproceedings{shi2020long,
  author = {Zhengliang Shi and Hua Zhang and Zhiyong Fan and Wei Ma and Yongzhou Song and Ming Li and Tong-qiu Li and Shuxing Cao and Guo-jun Feng},
  title = {{Long noncoding RNA LINC00314 facilitates osteogenic differentiation of adipose-derived stem cells through the hsa-miR-129-5p/GRM5 axis via the Wnt signaling pathway}},
  booktitle = {Stem},
  year = {2020},
  doi = {10.1186/s13287-020-01754-z},
}
Figure